Heterotricyclic cage compounds, processes for their production, pharmaceutical compositions containing them, and their use as medicinal antiviral agents
申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
公开号:EP0040944A1
公开(公告)日:1981-12-02
Compounds of the formula:
wherein A, is a single bond, a C2-C5 alkylene group or a C1-C5 alkylidene group, A2 is a C2-C3 alkylene group or a C1-C3 alkylidene group, A3 is a C2-C4 alkylene group or a C1-C4 alkylidene group, X is -O- or -SOn- (wherein n is an integer of 0 to 2), R, is a hydrogen atom, a C1-C5 alkyl group, a C3-C5 alkenyl group and R2 is a hydrogen atom, a C1-C5 alkyl group, a C3-C5 alkenyl group, a C2-C5 alkanoyl group, a C2-C5 alkoxycarbonyl group, a benzyloxycarbonyl group, or when taken together with the adjacent nitrogen atom, R, and R2 may form a five or six-membered heterocyclic group, which are useful as antiviral agents.
式中的化合物:
其中 A 为单键、C2-C5 亚烷基或 C1-C5 亚烷基,A2 为 C2-C3 亚烷基或 C1-C3 亚烷基,A3 为 C2-C4 亚烷基或 C1-C4 亚烷基,X 为 -O- 或 -SOn- (其中 n 为 0 至 2 的整数),R 为氢原子、C1-C5 烷基、C3-C5 烯基,R2 为氢原子、C1-C5 烷基、C3-C5 烯基、C2-C5 烷氧基、C3-C5 烯基、R2是氢原子、C1-C5烷基、C3-C5烯基、C2-C5烷酰基、C2-C5烷氧羰基、苄氧羰基,或者当 R 和 R2 与相邻的氮原子结合在一起时,可形成五元或六元杂环基团,可用作抗病毒剂。